Risk-Reducing Mastectomy and Breast Cancer Mortality in Patients With a BRCA Mutation
Posted: 04/10/2024 | By: Melissa E. Fryman, MS

In a study published by Metcalfe et al in the British Journal of Cancer, investigators examined how risk-reducing mastectomy may affect the rate of mortality in female patients with pathogenic BRCA1 or BRCA2 variants but no breast cancer diagnoses.

Question 1 of 5

In this study, risk-reducing mastectomy was offered to over 1,600 initially cancer-free women with a BRCA1 or BRCA2 pathogenic variant. The study design is best described as a:

Choose 1